The Inhibitory Effect of Eplerenone on Cell Proliferation in the Contralateral Kidneys of Rats with Unilateral Ureteral Obstruction

Nephron

Volumn 136, Issue 4, 2017, Pages 328-338

  Wang, Cong Hui ^a,d   Wang, Zheng ^b   Liang, Li Juan ^a   Wang, Xiang Ting ^b   Ma, Xue Lian ^b   Liu, Bei Bei ^d   He, Jia Qi ^b   Shimosawa, Tatsuo ^e,f   Xu, Qing You ^a,b,c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c Hebei Key Laboratory of Integrative Medicine on Liver Kidney Patterns   (China)

^d UNIVERSITY OF TOKYO   (Japan)

^e INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^f JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

Author keywords

Aldosterone; Contralateral kidney; Fibrosis; Inflammation; Mineralocorticoid receptor; Proliferation

Indexed keywords

ALDOSTERONE; COLLAGEN; CYCLINE; EPLERENONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; ACTIN; IMMEDIATE EARLY PROTEIN; MINERALOCORTICOID ANTAGONIST; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE; SMOOTH MUSCLE ACTIN, RAT; SPIRONOLACTONE; TUMOR NECROSIS FACTOR;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTRALATERAL KIDNEY; CONTROLLED STUDY; DRUG EFFECT; FIBROSING ALVEOLITIS; INFLAMMATORY CELL; KIDNEY; KIDNEY TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED; FIBROSIS; GENETICS; MAPK SIGNALING; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ACTINS; ALDOSTERONE; ANIMALS; CELL PROLIFERATION; COLLAGEN; FIBROSIS; IMMEDIATE-EARLY PROTEINS; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; URETERAL OBSTRUCTION;

EID: 85018466087     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000473702     Document Type: Article

References (26)

1. Cleper R: Mechanisms of compensatory renal growth. Pediatr Endocrinol Rev 2012; 10: 152-163.
2. Sergio M, Galarreta CI, Thornhill BA, Forbes MS, Chevalier RL: The fate of nephrons in congenital obstructive nephropathy: Adult recovery is limited by nephron number despite early release of obstruction. J Urol 2015; 194: 1463-1472.
3. Castle WN, Mcdougal WS: Contralateral renal hyperplasia and increased renal function after relief of chronic unilateral ureteral obstruction. J Urol 1984; 132: 1016-1020.
4. Dicker SE, Shirley DG: Compensatory hypertrophy of the contralateral kidney after unilateral ureteral ligation. J Physiol 1972; 220: 199-210.
5. Hauser P, Kainz A, Perco P, Bergmeister H, Mitterbauer C, Schwarz C, Regele HM, Mayer B, Meyer TW, Oberbauer R: Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy. Kidney Int 2005; 68: 2497-2507.
6. Bianchi S, Batini V, Bigazzi R: The renal effects of mineralocorticoid receptor antagonists. Int J Cardiol 2015; 200: 20-24.
7. Trachtman H, Weiser AC, Valderrama E, Morgado M, Palmer LS: Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction. J Urol 2004; 172(4 pt 2):1590-1594.
8. Chen H, Sun F, Zhong X, Shao Y, Yoshimura A, Liu Y: Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress. Kidney Blood Press Res 2013; 37: 557-566.
9. Brem AS, Gong R: Therapeutic targeting of aldosterone: A novel approach to the treatment of glomerular disease. Clin Sci (Lond) 2015; 128: 527-535.
10. Yuan Y, Zhang F, Wu J, Shao C, Gao Y: Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model. Sci Rep 2015; 5: 9314.
11. Chen KH, Hsu HH, Yang HY, Tian YC, Ko YC, Yang CW, Hung CC: Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway. Int J Biochem Cell Biol 2016; 74: 135-144.
12. Fan HY, Yang MY, Qi D, et al: Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats. Sci Rep 2015; 5: 12273.
13. Frokiaer J, Djurhuus JC, Nielsen M, Pedersen EB: Renal hemodynamic response to ureteral obstruction during converting enzyme inhibition. Urol Res 1996; 24: 217-227.
14. Lamouille S, Xu J, Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-196.
15. Somanna NK, Yariswamy M, Garagliano JM, et al: Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. Cell Signal 2015; 27: 1928-1938.
16. Wei J, Li Z, Ma C, et al: Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion. Cell Biol Int 2013; 37: 725-730.
17. Ando K, Ohtsu H, Uchida S, et al: Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: A double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2014; 2: 944-953.
18. Fujita T: Mechanism of salt-sensitive hypertension: Focus on adrenal and sympathetic nervous systems. J Am Soc Nephrol 2014; 25: 1148-1155.
19. Terada Y, Kuwana H, Kobayashi T, Okado T, Suzuki N, Yoshimoto T, Hirata Y, Sasaki S: Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. J Am Soc Nephrol 2008; 19: 298-309.
20. Bai JA, Xu GF, Yan LJ, Zeng WW, Ji QQ, Wu JD, Tang QY: SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis. World J Gastroenterol 2015; 21: 6180-6193.
21. Sheng L, Yang M, Ding W, et al: Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney. Exp Cell Res 2016; 346: 99-110.
22. Hughes J, Brown P, Shankland SJ: Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol 1999; 277(6 pt 2): F948-F956.
23. Clarke NW, Jones DA, Tames F, Laing I, George NJ: Disturbance in sodium regulating hormones in chronic obstructive uropathy. Br J Urol 1991; 68: 118-121.
24. Li C, Wang W, Norregaard R, Knepper MA, Nielsen S, Frokiaer J: Altered expression of epithelial sodium channel in rats with bilateral or unilateral ureteral obstruction. Am J Physiol Renal Physiol 2007; 293:F333-F341.
25. Le Y, Zheng Z, Xue J, et al: Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction. J Renin Angiotensin Aldosterone Syst 2016;-pii:1470320316677918.
26. Zhou X, Fukuda N, Matsuda H, Endo M, Wang X, Saito K, Ueno T, Matsumoto T, Matsumoto K, Soma M, Kobayashi N, Nishiyama A: Complement 3 activates the renal reninangiotensin system by induction of epithelialto-mesenchymal transition of the nephrotubulus in mice. Am J Physiol Renal Physiol 2013; 305:F957-F967.